AdalimumabExencephaly following in-utero exposure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1843卷 / 1期

关键词：

D O I：

10.1007/s40278-021-91119-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[1] DexamethasoneHypospadias following in-utero exposure: case report
Reactions Weekly, 2022, 1927 (1) : 217 - 217
[2] ThiamazoleGastroschisis following in-utero exposure: case report
Reactions Weekly, 2019, 1759 (1) : 250 - 250
[3] ColecalciferolHypercalcaemia following in-utero exposure: case report
Reactions Weekly, 2017, 1667 (1) : 92 - 92
[4] MetyraponeHyponatraemia following in-utero exposure: case report
Reactions Weekly, 2020, 1811 (1) : 186 - 186
[5] PropranololHypoglycaemia following in-utero exposure: case report
Reactions Weekly, 2016, 1611 (1) : 146 - 146
[6] PramipexoleHydronephrosis following in-utero exposure: case report
Reactions Weekly, 2023, 1970 (1) : 241 - 241
[7] MetforminPrematurity following in-utero exposure: case report
Reactions Weekly, 2023, 1957 (1) : 359 - 359
[8] FingolimodDextrocardia following in-utero exposure: case report
Reactions Weekly, 2018, 1695 (1) : 180 - 180
[9] WarfarinEmbryopathy following in-utero exposure: case report
Reactions Weekly, 2018, 1725 (1) : 293 - 293
[10] ThiamazoleHypothyroidism following in-utero exposure: case report
Reactions Weekly, 2019, 1748 (1) : 506 - 506

← 1 2 3 4 5 →